|
|
|
|
Trends in the epidemiology of dengue fever and their relevance for importation to Europe
Dengue fever continues to spread globally, causing major epidemics and putting major strain on health systems in affected countries.For imported dengue in Europe, south east Asia is the most important region of origin, followed by...
|
|
|
Co-infections with Chikungunya Virus and Dengue Virus in Delhi, India
_ Co-infections with Chikungunya Virus and Dengue Virus in Delhi, India.
|
|
|
NanoViricides, Inc. CEO Invited to Speak at NanoBio 2009 Conference
- NanoViricides, Inc.(OTC BB: NNVC.OB) (the 'Company'), announced today that its CEO, Dr. Eugene Seymour, has been invited to present a talk, and, in addition, participate in presenting a workshop on Nanoparticle Formulation: principles...
|
|
|
World's First Tetravalent Dengue Vaccine in Clinical Trial
_ World's First Tetravalent Dengue Vaccine in Clinical Trial.
|
|
|
Dengue maculopathy: visual electrophysiology and optical coherence tomography
Save in My Library Free Abstract Mendes TS et al.- The dengue fever can lead to visual impairment detectable by ophthalmological exams such as angiography, retinography, and OCT imaging, as well as retinal and cortical electrophysiology....
|
|
|
NanoViricides, Inc. CEO Invited to Speak at NanoBio 2009 Conference
- NanoViricides, Inc.(OTC BB: NNVC.OB) (the 'Company'), announced today that its CEO, Dr. Eugene Seymour, has been invited to present a talk, and, in addition, participate in presenting a workshop on Nanoparticle Formulation: principles...
|
|
|
NanoViricides, Inc. CEO Invited to Speak at NanoBio 2009 Conference
NanoViricides, Inc.(OTC BB: NNVC.OB) (the 'Company'), announced today that its CEO, Dr. Eugene Seymour, has been invited to present a talk, and, in addition, participate in presenting a workshop on Nanoparticle Formulation: principles...
|
|
|
DoctorsEUR Statements on the Dengue Epidemic
_ DoctorsEUR Statements on the Dengue Epidemic.
|
|
|
First climate-based biotechnology model of Dengue outbreaks
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World.Around 50-100 million cases appear each year putting 2.5 billion people at risk of suffering this...
|
|
|
Philippines Health Secretary Warns Of Impending Dengue Threat
News Archive [link] Web Wikipedia Medical Dictionary [link] login | register Tropical Diseases News Main Category: Tropical Diseases email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient /...
|
|
|
Dengue Fever - Researchers from Nanyang Technological University report details of new studies and findings in
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Dengue Fever Researchers from...
|
|
|
Scientists use climate variables and vegetation indices to predict and mitigate Dengue epidemics
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World.Around 50-100 million cases appear each year putting 2.5 billion people at risk of suffering this...
|
|
|
climate-based Model to Predict Dengue Fever Outbreaks Developed
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World.Around 50-100 million cases appear each year putting 2.5 billion people at risk of suffering this...
|
|
|
FDA Cites Diagnostics Maker for Several GMP Violations
IVD Research did not require its employees to conduct risk analyses or document design validations for several of its devices, according to an FDA warning letter.The agency cited the company for failure to establish and maintain written...
|
|
|
Flu A/H1N1 cases rise to 14 in Philippines
MANILA, May 29 (Xinhua) -- The Philippines has reported a total of 14 confirmed influenza A/H1N1 cases in the country following the confirmation of four more cases on Friday, according to the country's health department on Friday.Two of...
|
|
|
NanoViricides, Inc. Announces Additional Herpes Keratitis Study
cases of HSV infection of the cornea in the US alone each year.It is generally caused by HSV Type I. Many of these cases lead to substantial scarring of the cornea and significantly reduced vision, which may necessitate corneal...
|
|
|
Govt need to initiate research for developing anti viral drugs: Dr Rajarajan
Increasing thrust should be given to discovery and development of anti-viral drugs as the world is threatened with frequent outbreaks of viral diseases.New generation of anti-viral drug is the need of the hour. India is short of anti...
|
|
|
Sanofi-aventis to build new vaccine facility in France with Euro 350 mn
Sanofi-aventis, the world's leading vaccine manufacturer, officially launched the construction of a new Sanofi Pasteur vaccine manufacturing centre in Neuville-sur-Sane, France.The investment in this new vaccine production facility in...
|
|
|
New Understanding of Dengue Virus Points Way to Possible Therapies for Dengue Fever
Dengue fever is a mosquito-borne disease that's becoming more of a problem around the world.The range of dengue-carrying mosquitoes has spread from tropical into sub-tropical areas. And some countries have had ongoing dengue...
|
|
|
Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment
/PRNewswire-FirstCall/ -- Fincor, acquired a majority of ACTRx International Inc., which combines several natural drugs to fight Malaria and Dengue fever and looks to become a premier global supplier of Malaria and Dengue cures,...
|
|
|
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and
Pharmaceutical Patents Title: United States Patent: 7,517,531 Issued: April 14, 2009 Whitehead; Stephen S.(Montgomery Village, MD), Murphy; Brian R. (Bethesda, MD), Markoff; Lewis (Bethesda, MD), Falgout; Barry (Rockville, MD), Blaney;...
|
|
|
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded to Singapore and Vietnam
SINGAPORE, April 21 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today the start of clinical studies of its investigational tetravalent dengue vaccine in Singapore...
|
